Clinical Trials on Post-operative Analgesia in Belgium

Total 192 results

University of Liege

Terminated

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Chronic Graft-Versus-Host Disease | Acute Graft-Versus-Host Disease | Steroid Refractory Graft-Versus-Host Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Long-term Control in Rhinosinusitis After Functional Endoscopic Sinus Surgery (FESS)

Condition of Patient 3 Years After FESS-operation

Belgium
Amphora Medical, Inc.

Terminated

Cystoscopic Ablation Via RF Energy Clinical Trial (CARETI)

Overactive Bladder

Canada, Belgium
Amber Therapeutics Ltd

Active, not recruiting

AURA-2: Augmenting Urinary Reflex Activity (AURA-2)

Overactive Bladder | Urge Incontinence

Belgium
University Hospital, Antwerp
Hasselt University; Ziekenhuis Oost-Limburg; Universiteit Antwerpen

Active, not recruiting

Pulmonary Rehabilitation for Long COVID (Post COVID-19 Condition) (PuRe-COVID)

COVID-19 | Long COVID | Post COVID-19 Condition

Belgium
Hasselt University

Recruiting

Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

Post-Acute COVID-19 Syndrome

Belgium
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel

Completed

Nutrition and LOComotoric Rehabilitation in Long COVID-19 (UNLOCK)

COVID-19

Belgium
Axonics Modulation Technologies, Inc.

Completed

Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) (RELAX-OAB)

Overactive Bladder

Netherlands, France, Belgium, United Kingdom
University of Aarhus

Completed

Predictive Markers of the Effects of Opioid Therapy (ABILITY)

Chronic Pain | Opioid Analgesic Treatment Response

Belgium, Denmark, Slovenia
University Hospital, Ghent
Algemeen Ziekenhuis Maria Middelares; AZ Sint-Lucas Gent; AZ Jan Palfijn Gent

Not yet recruiting

Diversity in Patients With OAB (DOAB)

Overactive Bladder | Sacral Neuromodulation | Diversity | Onabotulinum Toxin A | Discrete Choice Experiment

Belgium
University of Liege

Completed

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

Hematological Malignancies

Belgium
Universiteit Antwerpen
UZA Foundation

Active, not recruiting

Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID (Cov-N-Psy)

Long COVID

Belgium
University Hospital, Ghent

Completed

The Angle of the Metacarpophalangeal Joint of the Thumb During Maximal Pinch Strength

Osteoarthritis Thumb | Post-traumatic; Arthrosis

Belgium
Universiteit Antwerpen

Recruiting

What is the Effect of Prolapse Surgery on Voiding? (PROVOID)

Overactive Bladder | Voiding Disorders | Pelvic Organ Prolapse | Stress Urinary Incontinence | Urge Incontinence

Belgium
University Hospital, Ghent

Completed

Trial Comparing Kaffes Stent With Plastic Prosthesis in the Treatment of Anastomotic Biliary Strictures Post Orthotopic Liver Transplantation

Biliary Strictures Post Liver Transplantation

Belgium
Universitair Ziekenhuis Brussel

Unknown

Patient Satisfaction After Patient-specific Jawline Augmentation

Congenital Deformity of Face | Post-traumatic Deformity

Belgium
Astellas Pharma Europe B.V.
Veeda Clinical Research

Completed

Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome) (VENICE)

Lower Urinary Tract Predominant Storage Symptoms

Belgium
Technical University of Munich
KU Leuven; Northern State University, Russia; Latvijas Universitates Medicinas

Completed

Post-ERCP Pancreatitis Prevention by Stent Insertion (PEPSI)

Post-ERCP Acute Pancreatitis

Belgium, Germany, Latvia, Russian Federation
Erasme University Hospital

Completed

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS) (MAGUS)

Diverticulum, Esophageal | Post Gastric Surgery Syndrome

Belgium
University Hospital, Antwerp

Recruiting

PERIoperative Holistic RIsk Factor SCreening in the Prevention of Persistent Pain (PERISCOPEcare)

Pain, Chronic Post-Surgical

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Neuromodulation for Central Post-stroke Pain: Mechanism, Safety and Outcome

Central Post-stroke Pain | CPSP

Belgium
University Hospital, Antwerp
Universitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis Brussel; Université... and other collaborators

Recruiting

Define Predictors for Posttransplant Diabetes Mellitus Study (DECODE)

Kidney Transplant; Complications | Post-transplant Diabetes Mellitus

Belgium
Jules Bordet Institute
Macopharma; Belgian Hematological Society

Recruiting

Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Refractory Chronic Graft Versus Host Disease (cGVHD)

Belgium
University of Liege

Recruiting

Neurological Blood-based Biomarkers and Cognitive Disorders in Critically Ill Survivors. (COGNISI)

Intensive Care Unit Syndrome | Cognitive Disorder | Post-intensive Care Syndrome

Belgium
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease (MATADOR)

Allogeneic Stem Cell Transplant | Acute Myeloid Leucaemia | Myelo Dysplastic Syndrome | Acute Graft Versus Host Disease Grade II-IV

Netherlands, Belgium
Erasme University Hospital

Completed

Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis

Post-ERCP Acute Pancreatitis

Taiwan, Belgium
MedtronicNeuro

Terminated

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)

Urinary Incontinence | Detrusor Overactivity | Neurogenic Overactive Bladder

Belgium, France, United Kingdom, Germany, Italy, Netherlands
Radboud University Medical Center
Universitaire Ziekenhuizen KU Leuven

Completed

Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections (PIRAÑA)

Acute Graft Versus Host Disease | Allogeneic Stem Cell Transplant | Acute Myeloid Leucaemia | Myelo Dysplastic Syndrome

Belgium, Netherlands
Astellas Pharma Inc

Completed

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Overactive Bladder | Neurogenic Detrusor Overactivity

Belgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
Universiteit Antwerpen

Recruiting

Comparison of a Paper and Automated Bladder Diary in Pediatric Patients

Overactive Bladder | Lower Urinary Tract Symptoms | Enuresis | Voiding Disorders

Belgium
Allergan

Completed

Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder

Poland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
Pfizer

Completed

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Neurogenic Detrusor Overactivity

Belgium
GZA Ziekenhuizen Campus Sint-Augustinus

Completed

Evaluation of Persistent Postsurgical Pain After Breast Surgery With a Pectoral Nerves Block (Pecs) Type II

Breast Cancer | Chronic Post-Procedural Pain

Belgium
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Overactive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor Overactivity

Belgium, Denmark, Norway, Poland, Serbia
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

Post-Traumatic Knee Osteoarthritis Following Anterior Cruciate Ligament Reconstruction

Anterior Cruciate Ligament Injuries | Post-Traumatic Osteoarthritis of Knee

Belgium
Allergan

Completed

A Research Study for Patients With Overactive Bladder

Overactive Bladder | Urinary Incontinence

Poland, Germany, United States, Canada, United Kingdom, Belgium
KU Leuven
Fund for Scientific Research, Flanders, Belgium

Completed

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation (AZI002)

Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation

Belgium
University Ghent

Recruiting

The Classification and Treatment of Myofascial Headache: a Cross-sectional Study and Randomized Controlled Trial. (COMPHAS_RCT)

Tension-Type Headache | Cervicogenic Headache | Myofascial Headache

Belgium
University of Liege

Completed

Effect of Repeated tDCS Sessions on Cognitive Improvement in Patients With Disorders of Consciousness (rtDCS in DOC)

Disorders of Consciousness | Severe Brain Injury | Post-comatose Non-communicative Patients

Belgium
General Hospital Groeninge

Active, not recruiting

Impact of a COVID-19 Related ICU Stay on Mental Health for Patients and Their Relatives (PICOVIDS)

COVID-19 | Mental Health | Critically Ill | Post Intensive Care Syndrome | PICS

Belgium
Pfizer

Completed

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Neurogenic Detrusor Overactivity

Belgium
KU Leuven
University Ghent

Recruiting

Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity (PHOENIX-Kidney)

Physical Activity | Kidney Transplantation | Exercise Training | Physical Fitness | Gut Microbiome | Cost-effectiveness | Implementation | Health-related Quality of Life | Cardiovascular Health

Belgium
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

United Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
Allergan

Completed

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
Allergan

Completed

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Germany, Canada, Belgium, United States, Czechia
University of Liege

Completed

Use of Analgesic Treatment to Reduce Signs of Pain in Patients With Disorders of Consciousness.

Disorders of Consciousness | Minimally Conscious State | Severe Brain Injury | Post-comatose Non-communicative Patients | Vegetative State

Belgium
Astellas Pharma Inc

Completed

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Urinary Bladder, Overactive

Sweden, United Kingdom, Belgium, Denmark
Population Health Research Institute
Hamilton Health Sciences Corporation

Recruiting

Low INR to Minimize Bleeding With Mechanical Valves Trial (LIMIT)

Bleeding Post-mechanical Valve Replacement | Thromboembolism Post-mechanical Valve Replacement

Canada, Spain, Belgium, Russian Federation, Netherlands, Brazil
Janssen-Cilag International NV
Alza Corporation, DE, USA

Completed

A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously (EuroTrans)

Pain | Pain, Postoperative | Analgesia, Patient-Controlled

France, United Kingdom, Germany, Spain, Switzerland, Sweden, Belgium, Austria, Denmark, Ireland
BlueWind Medical

Recruiting

BlueWind RENOVA iStim™ System for the Treatment of OAB (OASIS)

Treatment of Patients Suffering From Overactive Bladder (OAB)

United States, Belgium, Netherlands, United Kingdom

Clinical Trials on Post-operative Analgesia in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations